A detailed history of Orion Portfolio Solutions, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 26,934 shares of NBIX stock, worth $3.32 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,934
Previous 27,155 0.81%
Holding current value
$3.32 Million
Previous $3.74 Million 17.07%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$114.58 - $153.15 $25,322 - $33,846
-221 Reduced 0.81%
26,934 $3.1 Million
Q2 2024

Aug 13, 2024

SELL
$130.86 - $143.19 $236,856 - $259,173
-1,810 Reduced 6.25%
27,155 $3.74 Million
Q1 2024

May 09, 2024

SELL
$130.4 - $143.74 $63,896 - $70,432
-490 Reduced 1.66%
28,965 $3.99 Million
Q4 2023

Feb 09, 2024

SELL
$106.07 - $132.76 $291,586 - $364,957
-2,749 Reduced 8.54%
29,455 $3.88 Million
Q3 2023

Nov 01, 2023

BUY
$94.02 - $117.1 $375,421 - $467,580
3,993 Added 14.15%
32,204 $3.62 Million
Q2 2023

Aug 14, 2023

SELL
$89.53 - $104.87 $318,637 - $373,232
-3,559 Reduced 11.2%
28,211 $2.66 Million
Q1 2023

Aug 30, 2023

BUY
$94.11 - $123.02 $334,937 - $437,828
3,559 Added 12.62%
31,770 $3.22 Million
Q1 2023

May 15, 2023

BUY
$94.11 - $123.02 $2.99 Million - $3.91 Million
31,770 New
31,770 $3.22 Million
Q3 2020

Nov 13, 2020

SELL
$96.16 - $135.15 $3,269 - $4,595
-34 Closed
0 $0
Q2 2020

Aug 19, 2020

BUY
$85.09 - $130.36 $255 - $391
3 Added 9.68%
34 $4,000
Q1 2020

May 15, 2020

BUY
$75.11 - $113.76 $450 - $682
6 Added 24.0%
31 $3,000
Q4 2019

Feb 14, 2020

BUY
$86.8 - $118.57 $2,170 - $2,964
25 New
25 $3,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.